Oruka Therapeutics
The Director of Analytical Development and Validation will lead late-stage analytical activities for biologic drug products, focusing on method validation, comparability, and device functional testing to support regulatory submissions and commercial launch. This role provides scientific and strategic leadership, partners with CMC, Quality, and Regulatory teams, and mentors a high‑performing analytical development group.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Oruka Therapeutics.
8% above the average for this role
Senior Manager, Analytical Sciences
Summit Therapeutics,
Associate Director of CMC Analytical Development
Syncromune®
Analytical Lead and Expert Preclincal Bioassays - all genders -
sanofi us
Biologics- Analytical Lead 1
Syngene International Limited
Associate Director of Analytical Development and CMC Statistics
Summit Therapeutics,
Senior Manager or Associate Director, Analytical Development
GSK plc